DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE
申请人:Axovant Sciences GmbH
公开号:US20210177804A1
公开(公告)日:2021-06-17
The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT
2A
serotonin receptor and their uses for the treatment and prophylaxis of visual hallucinations associated with Lewy Body dementia.